Longitude Prize
Enter the prize
0
To coincide with the second Longitude Prize Sprint workshop focused on regulation, we spoke to investment expert David Gill, Managing Director, St. Johns Innovation Centre to capture his advice to innovators working in this space.
Daniel Berman, Head of Global Health at Nesta Challenges, is speaking at next week’s AMR Conference 2020. Berman will make the case for a dramatic rethink of the roles and responsibilities of medtech companies and multinational generic makers, calling for a mechanism to pool “pharmerging” market* demand. Read more here.
On 7 August 2020, we brought together top experts from across the world to explore the subtle and distinct variations in regulatory standards for med-tech products across different geographies, especially between developed and developing countries. With 70 international attendees, featuring a mix of Longitude Prize competitors, researchers and other players in the product development space, we had a lively call full of learning and debate.
The Longitude Prize, has launched a new programme of activity focused on accelerating innovation in diagnostic tests that are essential to managing the spread of AMR worldwide.
The UK Department of Health and Social Care (DHSC) recently announced a new approach for the procurement and provision of new antibiotics in the NHS, through a subscription-style’ payment model. The news represents a total re-think of how antibiotics are valued in public health.
CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) has today awarded a $3.2m grant to Longitude Prize contender Module Innovations for its ASTSENSe diagnostic.
In February, we hosted a symposium with the Royal College of Nursing (UK), bringing together doctors, nurses, test developers and patients to draw attention to the impact of urinary tract infections (UTIs) and showcase the near-to-market solutions that will transform treatment for patients and clinicians. We’ve written a blog on the outcomes of the day.